Pharmaceutical expenditure and therapeutic value of new medicines in Spain.
Josep
J
Darba
D003363:Cost Control / Q000639:trends; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000331:legislation & jurisprudence / Q000639:trends*; D004345:Drug Industry / Q000191:economics; D005252:Fees, Pharmaceutical / Q000331:legislation & jurisprudence / Q000639:trends*; D005102:Health Expenditures / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000191:economics*; D012051:Reimbursement Mechanisms / Q000331:legislation & jurisprudence / Q000639:trends; D013030:Spain; D013222:State Medicine / Q000191:economics
D004364:Pharmaceutical Preparations